RY-PT Financial Statements & Analysis
Complete financial statements for RY-PT including income statement, balance sheet, and cash flow statement. Analyze RY-PT's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
Income Statement
Revenue
153.8% ↑
Net Income
25.5% ↑
Gross Margin
-54.7% ↓
Operating Margin
-59.2% ↓
Balance Sheet
Current Ratio
-2.7% ↓
Debt to Equity
-2.1% ↑
Asset Turnover
137.1% ↑
Cash Flow
Operating Cash Flow
138.6% ↑
Net Cash Flow
-274.1% ↓
Free Cash Flow
154.0% ↑
Cash Flow to Debt
122.8% ↑
Income Statement Comparison
Revenue & Net Income
Period Comparison
| Metric | 2024 | 2025 | Change | Impact |
|---|---|---|---|---|
| Revenue | 54.11B | 137.36B | 153.8% | |
| Gross Profit | 54.11B | 62.17B | 14.9% | |
| Operating Income | 24.79B | 25.65B | 3.5% | |
| Net Income | 16.23B | 20.36B | 25.5% | |
| EPS | 11.25 | 14.10 | 25.3% | |
| EBITDA | 2.98B | 28.73B | 863.8% | |
| Gross Margin | 100.00% | 45.26% | 54.7% | |
| Operating Margin | 45.82% | 18.67% | 59.2% | |
| Net Income Margin | 29.99% | 14.82% | 50.6% | |
| R&D Expenses | 0 | 0 | 0.0% |
Income Statement Full Table
Free users can view the last 3 periods. Upgrade to see the full history.
Upgrade| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 137.36B | 54.11B | 49.00B | — | — |
| Gross Profit | 62.17B | 54.11B | 49.00B | — | — |
| Operating Income | 25.65B | 24.79B | 22.71B | — | — |
| Net Income | 20.36B | 16.23B | 14.61B | — | — |
| EPS | 14.10 | 11.25 | 10.51 | — | — |
| EBITDA | 28.73B | 2.98B | 2.85B | — | — |
| Gross Margin | 45.26% | 100.00% | 100.00% | — | — |
| Operating Margin | 18.67% | 45.82% | 46.35% | — | — |
| Net Income Margin | 14.82% | 29.99% | 29.81% | — | — |
| R&D Expenses | 0 | 0 | 0 | — | — |
Financial Metrics
Want to dive deeper into RY-PT's financial health? Explore key financial metrics and ratios including profitability, liquidity, efficiency, and valuation metrics.
View Financial Metrics